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Background: Immunoregulatory capacity of mesenchymal stem cells (MSC) is triggered by the inflammatory
environment, which changes during tissue repair. Macrophages are essential in mediating the inflammatory response
after injury and can adopt a range of functional phenotypes, exhibiting pro-inflammatory and anti-inflammatory
activities. An accurate characterization of MSC activation by the inflammatory milieu is needed for improving the
efficacy of regenerative therapies. In this work, we investigated the immunomodulatory functions of MSC primed with
factors secreted from macrophages polarized toward a pro-inflammatory or an anti-inflammatory phenotype. We
focused on the role of TNF-α and IL-10, prototypic pro-inflammatory and anti-inflammatory cytokines, respectively,
as priming factors for MSC.
Methods: Secretion of immunoregulatory mediators from human MSC primed with media conditioned by human
macrophages polarized toward a pro-inflammatory or an anti-inflammatory phenotype was determined.
Immunomodulatory potential of primed MSC on polarized macrophages was studied using indirect co-cultures.
Involvement of TNF-α and IL-10 in priming MSC and of PGE2 in MSC-mediated immunomodulation was investigated
employing neutralizing antibodies. Collagen hydrogels were used to study MSC and macrophages interactions in a
more physiological environment.
Results: Priming MSC with media conditioned by pro-inflammatory or anti-inflammatory macrophages enhanced their
immunomodulatory potential through increased PGE2 secretion. We identified the pro-inflammatory cytokine TNF-α as
a priming factor for MSC. Notably, the anti-inflammatory IL-10, mainly produced by pro-resolving macrophages,
potentiated the priming effect of TNF-α. Collagen hydrogels acted as instructive microenvironments for MSC and
macrophages functions and their crosstalk. Culturing macrophages on hydrogels stimulated anti-inflammatory versus
pro-inflammatory cytokine secretion. Encapsulation of MSC within hydrogels increased PGE2 secretion and potentiated
immunomodulation on macrophages, attenuating macrophage pro-inflammatory state and sustaining anti-
inflammatory activation. Priming with inflammatory factors conferred to MSC loaded in hydrogels greater immunomodulatory
potential, promoting anti-inflammatory activity of macrophages.
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Conclusions: Factors secreted by pro-inflammatory and anti-inflammatory macrophages activated the immunomodulatory
potential of MSC. This was partially attributed to the priming effect of TNF-α and IL-10. Immunoregulatory functions of
primed MSC were enhanced after encapsulation in hydrogels. These findings may provide insight into novel strategies
to enhance MSC immunoregulatory potency.
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Tissue repairBackground
The inflammatory response to tissue injury is essential for
the correct restoration of tissue structure and function.
However, an uncontrolled or unresolved inflammatory
process can lead to chronic inflammation and further tis-
sue damage. Macrophages are key regulators of wound
healing and are involved in both advancing and resolving
inflammation by secreting multiple cytokines and growth
factors. Macrophages exhibit functional transitions as
tissue repair progresses and can adopt a wide spectrum of
phenotypes. Two of the best-characterized phenotypes
are pro-inflammatory or M1-like phenotype and anti-
inflammatory or M2-like phenotype. M1 macrophages
produce high levels of pro-inflammatory cytokines and are
related to the early stage of inflammation whereas M2
macrophages, with lower pro-inflammatory cytokine
production, are associated with the resolution of inflam-
mation and tissue repair [1]. There is evidence that mac-
rophages can display more complex phenotypes with
traits associated with both M1 and M2 activation states [2,
3]. In addition, mixed populations of macrophages have
been identified [4, 5]. Functional repolarization of macro-
phages toward an anti-inflammatory phenotype ensures
proper return to homeostasis after injury and is mediated
by a large panel of mediators including prostaglandin
E2 (PGE2) [6]. Several studies suggest that an incorrect
balance between M1- and M2-like activities after injury
can lead to persistent inflammation and/or maladaptive
repair processes, both contributing to aberrant tissue re-
pair [7, 8]. Due to their critical role during wound healing,
macrophages have emerged as potential targets in thera-
peutic tissue regeneration strategies [9].
Accumulating evidence suggests that mesenchymal
stem cells (MSC) promote tissue repair and regeneration
through modulation of immune response and secretion of
growth factors rather than by replacement of damaged
cells. MSC release a wide range of immunoregulatory
factors including PGE2 and interleukin-6 (IL-6) that skew
macrophages toward a pro-resolving profile [10]. Immu-
noregulatory capacity of MSC is not constitutive, but
depends on a process of “licensing” that implies the activa-
tion of MSC by the inflammatory milieu. Thus, in re-
sponse to inflammatory mediators, MSC produce solublefactors that regulate the immune response. The require-
ment of MSC activation to induce immunoregulation is
supported by data showing that suppression of T cells pro-
liferation induced by MSC in co-cultures was only
achieved after addition of sufficient levels of interferon-γ
(IFN-γ) and tumor necrosis factor-α (TNF-α) [11–13].
Macrophages plasticity leads to changes in the balance
between pro-inflammatory and anti-inflammatory factors
as tissue is healed and remodeled. The earliest events
trigger the release of numerous pro-inflammatory media-
tors, which are followed by a shift to increased production
of anti-inflammatory cytokines and growth factors to
allow tissue repair [14]. Additionally, pro-inflammatory
and anti-inflammatory cytokine expression can be in-
duced simultaneously at early stages of inflammation
[15]. Given the variability of macrophage activation
states throughout the course of inflammation and tissue
repair, it is expected that MSC establish interactions
with different macrophage phenotypes and that both
pro-inflammatory and anti-inflammatory cytokines
influence MSC-mediated immunomodulation. To date,
the effects of the cocktail of factors originated from
pro-inflammatory or anti-inflammatory macrophage
populations on immunomodulatory properties of MSC
have not been described.
MSC, like all somatic tissues, express human leukocyte
antigens (HLA) class I constitutively and have the ability
to express HLA class II when exposed to inflammatory
factors. The HLA class I antigens are associated with the
activation of CD8+ T lymphocytes while HLA class II
antigens are recognized by CD4+ T lymphocytes. MSC
appear to evade immune rejection by modulating T cell
phenotype and immunosuppressing the local environ-
ment. A number of clinical trials involving allogeneic
MSC transplantation have shown overall safety and poten-
tial effectiveness [16]. MSC have been employed in the
clinical treatment of graft-versus-host disease (GvHD) due
to their ability to inhibit proliferation and cytotoxic activ-
ity of immune system cells. A limited number of clinical
trials have reported humoral alloimmunization in human
subjects receiving mismatched MSC, but it remains un-
clear whether this has an impact on their therapeutic effi-
cacy [17]. There is growing interest in combining MSC
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proteins that resemble the microenvironments where they
reside in order to prolong cell survival, potentiate their
function, and prevent rejection by the host [18, 19]. In this
work, we extensively investigated the immunomodulatory
functions of human MSC activated with secreted factors
from human monocyte-derived macrophages polarized
toward a pro-inflammatory or an anti-inflammatory
phenotype using standard two-dimensional (2D) culture
conditions. We focused on the role of TNF-α and IL-10,
prototypic pro-inflammatory and anti-inflammatory cyto-
kines, respectively, as priming factors for MSC. Immuno-
regulatory potential of MSC was evaluated in co-cultures
with pro-inflammatory or anti-inflammatory macrophage
populations. The assays that led to the most informative
data were then performed using MSC encapsulated in col-
lagen hydrogels, which represent a more physiological
relevant model.
Methods
Isolation and culture of primary human macrophages
Buffy coats were obtained from 30 healthy blood donors, as
anonymously provided by the Comunidad de Madrid Blood
Bank (Madrid, Spain). Ethical approvals for all blood
sources and processes used in this study were approved by
the Human Research Committee of Hospital Universitario
La Paz (Date of Approval: 03/06/2015). All experiments
were carried out in accordance with the approved guide-
lines and regulations. Human peripheral blood mono-
nuclear cells (PBMC) were isolated from buffy coats by
density gradient centrifugation using Ficoll-Paque Plus (GE
Healthcare Bio-sciences, Uppsala, Sweden). For monocyte
isolation, PBMC were seeded at a density of 15 × 106/well
in six-well plates and allowed to adhere for 1 h in
serum-free RPMI (Lonza, Basel, Switzerland). Adherent
cells were cultured for 7 days in RPMI supplemented with
10% (v/v) heat-inactivated fetal bovine serum (FBS) and
200U/ml of granulocyte macrophage-colony stimulating
factor (GM-CSF) or 20 ng/ml macrophage-colony stimulat-
ing factor (M-CSF) (both from Peprotech, London, UK).
Cytokines were added every 2 days. Macrophages generated
in the presence of GM-CSF or M-CSF are referred to as
MΦGM and MΦM, respectively. Conditioned media (CM)
were obtained from MΦGM or MΦM that were treated or
not with 10 ng/ml lipopolysaccharide (LPS) (Sigma, Madrid,
Spain) for 90min, washed three times with phosphate-
buffered saline (PBS), and cultured in RPMI medium sup-
plemented with 10% FBS for 5 h. The CM were clarified by
centrifugation at 1200g for 10min. The experimental
scheme used to generate CM is shown in Fig. 1a.
MSC culture and co-culture with macrophages
Purified human bone marrow-derived MSC were pur-
chased from Lonza and expanded in a defined medium(Lonza) consisting of basal medium and supplement
mix. All experiments were performed between passages
5 and 7 using cells isolated from six different donors
aged 18–30 years. 105 MSC were seeded in the upper
chamber of a 24-mm-diameter transwell insert with
0.4-μm pores (Corning, Lowell, MA, USA) and incu-
bated for 48 h in 3 ml of DMEM supplemented with
15% (v/v) heat-inactivated FBS or in 3ml of a mixture of
equal volumes of DMEM with 15% FBS and CM from
macrophages. When indicated and prior to addition to
MSC, CM were incubated for 1 h at 37 °C with 1 μg/ml
neutralizing antibody against TNF-α or IL-10 (Biole-
gend, San Diego, CA, USA). Parallel sets of MSC were
treated for 48 h with 1 or 10 ng/ml TNF-α, 0.1 or 1 ng/ml
IL-10, or combinations of both cytokines (Peprotech).
These doses were selected based on the concentrations of
TNF-α and IL-10 in the mixtures of DMEM and CM from
LPS-stimulated MΦGM or MΦM used for MSC treat-
ments. MSC treated with CM or cytokines are referred to
as primed MSC. The transwells with unprimed or primed
MSC were washed with PBS and transferred to six-well
plates containing cultures of MΦGM or MΦM and incu-
bated for 24 h in 3ml of a mixture of equal volumes of
RPMI and DMEM containing 12.5% FBS and 10 ng/ml
LPS. When indicated, 1 μg/ml antibody against PGE2
(Cayman Chemical Company, Ann Arbor, MI, USA) or
IL-6 (R&D Systems, Wiesbaden, Germany) was added
along with LPS. At the end of the incubation period, the
number of live macrophages was determined by the
trypan blue dye exclusion test. The experimental scheme
used for setting co-cultures is shown in Fig. 1a. In some
experiments, 105 MSC were seeded in 12-well plates and
incubated with CM or cytokines as described above. After
48 h, MSC were washed with PBS and further incu-
bated for 24 h in fresh culture media, as shown in
the experimental scheme in Fig. 4a. To assess that
MSC modulate cytokine secretion of stimulated
macrophages in the absence of LPS, macrophages
were treated with LPS for 90 min, washed with PBS,
and then co-cultured with MSC for 5 h in fresh
media (see experimental scheme in Additional file 1:
Figure S2).
Collagen gel co-cultures
Hydrogels (HG) containing 1.5mg/ml collagen were pre-
pared by mixing at 4 °C 40 μl of 10X DMEM, 10 μl of 1 N
NaOH, 162 μl of H2O, 8 μl of 7.5% NaHCO3, 100 μl of
serum-free DMEM, and 180 μl of 5 mg/ml rat-tail type I
collagen diluted in 0.1M acetic acid (Ibidi GmbH,
Martinsried, Germany). 105 MSC, previously treated or
not for 48 h with CM, were resuspended in 100 μl of
serum-free DMEM and added to the solution. HG-lacking
cells were used as controls. After homogenizing the mix-
ture by pipetting, 600 μl of suspension were distributed
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Fig. 1 Immunomodulatory effects of MSC primed with CM from macrophages. a Scheme used to generate conditioned media (CM) from macrophages
(upper row). MΦGM or MΦM were treated (CMGM or CMM, respectively) or not (CMGM− or CMM−, respectively) with LPS for 90min, thoroughly washed
with PBS to remove LPS, and incubated in fresh media for 5 h. Scheme of the set-up of co-cultures (lower row). MSC were incubated or not with CM
from macrophages or with cytokines for 48 h, thoroughly washed with PBS, and co-cultured with MΦGM or MΦM in the presence of LPS for
24 h. b Levels of inflammatory cytokines in CM of MΦGM or MΦM stimulated or not with LPS. Number of MΦGM (c) or MΦM (d) cultured in isolation or
co-cultured with MSC primed or not (−) with CM (left graphs) and levels of TNF-α (middle graphs) and IL-10 (right graphs) in media. *p < 0.05. N.D.,
not detected
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min. After polymerization, 600 μl of RPMI supplemented
with 25% (v/v) FBS were added and 2 × 105 MΦGM orMΦM were seeded onto HG loaded or not with MSC.
Then, HG media were supplemented with 10 ng/ml LPS
and incubated for 24 h. For comparative purposes,
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culture plastic (TCP) and incubated for 24 h in 1200 μl of
a mixture of equal volumes of RPMI and DMEM contain-
ing 12.5% FBS and 10 ng/ml LPS. In the case of MSC, cells
were seeded on TCP or encapsulated in HG and further
incubated for 24 h in the same media without LPS. The
experimental scheme used is shown in Fig. 8a. The cell
morphology was observed under a phase-contrast micro-
scope (Nikon Diaphot, Tokio, Japan).
Flow cytometry assays
Immunofluorescence staining of cell surface antigens in
MSC was performed by incubating cells for 30min at 4 °C
in the dark with mouse anti-human leukocyte antigen
(HLA)-DR, DP, DQ (HLA class II)-FITC, HLA-ABC
(HLA class I)-APC, CD34-FITC, CD44-FITC, CD105-PE,
CD29-APC, and CD45-APC Abs (all from BD Biosci-
ences, San Jose, CA,USA). Phenotypic characterization of
macrophages generated by incubation with GM-CSF or
M-CSF was assessed by staining with CD163-PE, CD197
(CCR7)-FITC, and CD80-APC (all from Miltenyi Biotec,
Bergisch-Gladbach, Germany). Cells incubated in the ab-
sence of antibodies were used as controls. After incuba-
tion, cells were washed three times with PBS, fixed with
1% (w/v) formaldehyde in PBS, and analyzed by flow cy-
tometry using a FACSCalibur analyzer and CellQuest soft-
ware (both from BD Biosciences).
Immunoenzymatic assays
The culture media were clarified by centrifugation at
1200g for 10 min; supplemented with 2 μg/ml aprotinin,
17.5 μg/ml phenyl-methylsulfonyl fluoride, 1 μg/ml pep-
statin A, and 50 μg/ml bacitracin (Sigma); and stored at
− 80 °C. Levels of TNF-α, IL-10, and IL-6 in cell culture
media were determined using BD CBA Flex Sets (BD
Biosciences). The data were acquired using a FACSCali-
bur flow cytometer and analyzed with the FCAP Array
Software version 3.0 (BD Biosciences). The detection
limits of the CBA Flex Sets were 3.7 pg/ml for TNF-α,
2.5 pg/ml for IL-6, and 3.3 pg/ml for IL-10. PGE2 levels
were measured using a human-specific ELISA kit
(Cayman) with a detection limit of 15 pg/ml.
Gene expression
Total RNA was isolated using TRI Reagent (Molecular Re-
search Center, Inc., Cincinnati, OH, USA). Complemen-
tary DNAs were prepared from total RNA using the
Transcriptor Reverse Transcriptase and an anchored-oligo
(dT)18 primer (Roche Applied Science, Indianapolis, IN,
USA). Real-time quantitative PCR was performed using
LightCycler FastStart DNA Master SYBR Green I and
LightCycler detector (Roche). Quantitative expression
values were extrapolated from standard curves and were
normalized to glyceraldehyde 3-phosphate dehydrogenase(GAPDH) values. Specific oligonucleotide primers were
IL-6, 5′-CCCCAGGAGAAGATTCCAAA-3′ (forward pri-
mer, F), 5′-CCAGTGATGATTTTCACCAGG-3′ (reverse
primer, R); cyclooxygenase-2 (COX-2), 5′-TGAGCATCT
ACGGTTTGCTG-3′ (F), 5′-TGCTTGTCTGGAACAAC
TGC-3′ (R); and GAPDH, 5′-GTGAAGGTCGGAGTCAA
CG-3′ (F), 5′-GAAGATGGTGATGGGATTTCC-3′ (R).
Statistical analysis
The statistical analyses were performed using the Statis-
tical Program for Social Sciences version 11.5 (SPSS Inc.,
Chicago, IL, USA). Data are presented as means ± SD of
six independent experiments. Quantitative data were
tested using two-sided Kruskal-Wallis and Mann-Whitney
U rank-sum tests. Post hoc comparisons were analyzed by
the Mann-Whitney U test, adjusting the p value with the
Bonferroni correction, and the level of significance was set
to p < 0.05.
Results
Priming MSC with factors secreted by pro-inflammatory
or anti-inflammatory macrophages enhances their
immunomodulatory potential
We primed MSC with CM from MΦGM or MΦM stimu-
lated or not with LPS to examine the influence of
inflammatory cytokines on MSC immunomodulatory po-
tential (Fig. 1a). MΦGM expressed the M1 markers CD80
and CCR7 whereas they were devoid of cell surface
CD163, a marker of M2 macrophages. In contrast, MΦM
expressed high levels of CD163 and very low levels of
CD80 and CCR7 (Additional file 1: Figure S1). The con-
centrations of inflammatory cytokines in the CM from
MΦGM or MΦM correlated with their pro-inflammatory
or anti-inflammatory phenotype, respectively (Fig. 1b).
CM from LPS-stimulated MΦGM (CMGM) contained
higher levels of TNF-α and IL-6 and lower levels of IL-10
than CM from LPS-stimulated MΦM (CMM). IL-10 levels
could not be detected in CM from unstimulated macro-
phages, which contained low concentrations of TNF-α
and IL-6 (Fig. 1b). To evaluate their immunomodulatory
potential, MSC primed or not with CM were co-cultured
with MΦGM or MΦM as shown in Fig. 1a. MSC did not
affect macrophage viability, as numbers of live MΦGM or
MΦM cultured in isolation or co-cultured with primed or
unprimed MSC were similar (Fig. 1c, d, left panels).
Co-culture of MΦGM with unprimed MSC decreased
TNF-α levels, an effect also observed in co-cultures of
MΦM (Fig. 1c, d, middle panels). MSC primed with CM
from unstimulated macrophages had no effect on TNF-α
secretion from MΦGM or MΦM (Fig. 1c, d, middle panels).
However, MSC primed with CM from LPS-stimulated
macrophages further decreased TNF-α levels in
co-cultures and no differences were found between prim-
ing with CMGM or CMM (Fig. 1c, d, middle panels). The
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co-cultured with unprimed MSC or CMM-primed MSC
but increased in co-cultures with CMGM-primed MSC
(Fig. 1c, right panels). IL-10 production by MΦM was not-
ably reduced in co-cultures with unprimed MSC (Fig. 1d,
right panels). However, this reduction was not observed
when MSC were primed with CMGM or CMM. As ob-
served for TNF-α, IL-10 levels in co-cultures were un-
affected by priming MSC with CM from unstimulated
macrophages (Fig. 1c, d, right panels). To assess that MSC
can modulate TNF-α and IL-10 secretion of stimulated
macrophages in the absence of LPS, macrophages were
treated with LPS, washed, and then co-cultured with MSC
in fresh media (Additional file 1: Figure S2). Under these
conditions, MSC decreased TNF-α levels in co-cultures
with MΦGM or MΦM and priming MSC with CMGM or
CMM increased their immunomodulatory properties, as
observed in co-cultures treated with LPS. Also, changes in
IL-10 levels induced by MSC were similar in co-cultures
with or without LPS. Taken together, our data show that
MSC primed with CM from LPS-stimulated macrophages,
which contain high levels of inflammatory mediators,8000
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Fig. 2 TNF-α and IL-10 prime MSC to regulate cytokine secretion from pro-in
cultured in isolation or co-cultured with MSC primed or not (−) with CMGM or
against TNF-α or IL-10. b TNF-α and IL-10 levels in media of MΦGM cultured in
doses of TNF-α, IL-10 or combinations of both cytokines. *p < 0.05display greater immunomodulatory potential than un-
primed MSC.
TNF-α and IL-10 in CM from macrophages are involved in
priming MSC
We next investigated the role of the pro-inflammatory
TNF-α and the anti-inflammatory IL-10 cytokines as
priming factors for MSC. For this purpose, CM from
macrophages were incubated with neutralizing TNF-α or
IL-10 antibody before being added to MSC. Treatment
of CMGM or CMM with anti-TNF-α reduced the ability
of primed MSC to decrease TNF-α levels in co-cultures
of MΦGM (Fig. 2a, left panel). Interestingly, a modula-
tory effect on TNF-α secretion was also observed when
CMM, which contained high IL-10 amounts, were
treated with anti-IL-10. IL-10 secretion induced by
CMGM-primed MSC in co-cultures of MΦGM was atten-
uated when CM were incubated with anti-TNF-α (Fig. 2a,
right panel). Neutralization of IL-10 in CMGM had no ef-
fect on TNF-α and IL-10 levels (Fig. 2a). To further in-
vestigate the effect of TNF-α and IL-10 on MSC, cells
were incubated with these cytokines before co-culturingIL
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on MSC immunomodulation. TNF-α levels in co-
cultures were also unaffected by priming MSC with ei-
ther IL-10 or TNF-α at 1 ng/ml, but decreased after in-
cubation with both cytokines (Fig. 2b, left panel).
Priming MSC with 10 ng/ml TNF-α diminished TNF-α
levels in co-cultures, which further decreased when
MSC were primed with 10 ng/ml TNF-α plus 1 ng/ml
IL-10. Finally, IL-10 levels in co-cultures increased only
when MSC were primed with 10 ng/ml TNF-α, alone or
in combination with IL-10 (Fig. 2b, right panel). Regard-
ing co-cultures of MΦM, neutralization of TNF-α in
CMGM or CMM reduced the ability of primed MSC to
modulate TNF-α levels without affecting IL-10 (Fig. 3a).
Moreover, blocking IL-10 in CMM suppressed the regu-
latory effects of primed MSC. Priming effects of TNF-α
on MSC in co-cultures of MΦM increased when 1 ng/ml
IL-10 was added (Fig. 3b, left panel). Notably, IL-10
levels increased when MΦM were co-cultured with MSC
primed with 1 ng/ml of IL-10 independently of the
presence of TNF-α (Fig. 3b, right panel). Overall, these
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ulatory potential.
Immunomodulatory effects of primed MSC on macrophages
are mediated by PGE2
Next, we examined whether the soluble mediators PGE2
and IL-6 are involved in the immunomodulation medi-
ated by primed MSC. Priming MSC with CM resulted in
increased secretion of IL-6, which reached higher levels
after incubation with CMGM than with CMM (Fig. 4b,
left panel). To explore whether TNF-α and IL-10 origi-
nated from macrophages play a role in this regulation,
CM were incubated with neutralizing antibodies. The
increase in IL-6 secretion induced by CMGM or CMM
was attenuated by blocking TNF-α but not IL-10. Inter-
estingly, PGE2 production increased to a similar extent
in MSC primed with CMGM or CMM and this effect was
largely attenuated by neutralizing TNF-α (Fig. 4b, right
panel). Blocking IL-10 decreased PGE2 levels secreted by
MSC primed with CMM but not with CMGM. Incubation
of MSC with TNF-α but not IL-10 induced a
dose-dependent increase in IL-6 and PGE2 secretionIL
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ation with high doses of IL-10 secreted higher PGE2 levels
than MSC treated with TNF-α alone (Fig. 4c, right panel).
This effect was not observed for IL-6 secretion (Fig. 4c,
left panel). IL-6 levels were substantially higher in
single-cultured MΦGM than in MΦM whereas PGE2 secre-
tion was similar for both macrophage phenotypes (Fig. 5a).
Co-culturing with primed or unprimed MSC led to a
similar increase in IL-6 levels (Fig. 5a, left panel). PGE2
levels also increased upon co-culturing MΦGM or MΦM
with MSC although increased further when MSC were
primed with CM (Fig. 5a, right panel). No differences were
found between priming with CMGM or CMM. Next,
mRNA levels of IL6 and COX2, a key enzyme in PGE2
synthesis, were determined in MSC cultured in isolationor co-cultured with macrophages. IL6 and COX2 mRNA
levels in single-cultured MSC correlated with IL-6 and
PGE2 secretion profiles (Figs. 5b and 4b). IL6 mRNA
levels increased after priming MSC with CM, but to a
higher extent with CMGM than with CMM. In contrast,
COX2 transcript levels increased to the same extent after
exposure to CMGM or CMM (Fig. 5b). IL6 and COX2
mRNA levels in MSC substantially increased when
co-cultured with macrophages. Similar to that observed at
the secretion level, COX2 mRNA levels in primed MSC
co-cultured with macrophages were higher than those in
unprimed counterparts whereas these differences were
not found in IL6 transcript (Fig. 5b). These results indicate
that priming with CM may potentiate the secretion of
PGE2 from MSC in co-cultures but not of IL-6.
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macrophages was regulated by PGE2 and IL-6, co-cultures
were incubated with neutralizing antibodies against these
mediators. TNF-α levels were similar in co-cultures incu-
bated with anti-PGE2 and in macrophages cultured in iso-
lation (Fig. 6a, b, left panels). In contrast, TNF-α levels in
co-cultures treated with anti-IL-6 were lower than in
isolated macrophages. The regulation in TNF-α levels in-
duced by MSC primed with CMGM or CMM was sup-
pressed by blocking PGE2 but not IL-6 (Fig. 6a, b, left
panels). IL-10 levels in co-cultures were hardly affected by
incubation with neutralizing antibodies. The only effect
was observed in co-cultures of MΦGM as the increase in
IL-10 levels induced by CMGM-primed MSC was attenu-
ated when PGE2 was blocked (Fig. 6a, right panel). These
data show that primed MSC co-cultured with macro-
phages decrease TNF-α levels through the secretion
of PGE2. PGE2 is also involved in the regulation of
IL-10 in co-cultures of primed MSC with MΦGM but
not with MΦM.Primed MSC encapsulated in collagen hydrogels promote
macrophage anti-inflammatory versus pro-inflammatory
cytokine secretion
Immune rejection of allogeneic MSC has been associated
with an alteration in HLA expression following exposure
to inflammatory factors [20, 21]. Cell surface levels of
HLA class I increased after treatment of MSC with CM,
while no effect was observed for HLA class II (Fig. 7).
Expression levels of other cell surface molecules related
to MSC identity were not altered by CM treatment
(Fig. 7). Encapsulation of MSC in HG has been proposed
as a strategy to enhance their survival after transplant-
ation and potentiate their function. We extended our
study to explore the immunomodulatory properties of
CM-primed MSC encapsulated in collagen HG, where
cells are permitted to grow in three dimensions. To this
end, MΦGM or MΦM were seeded on HG, loaded or not
with MSC, and stimulated with LPS. Macrophages or
MSC were also cultured on TCP, as classical 2D cell
growth conditions (Fig. 8a). On TCP, most MΦGM
ab
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of MΦM exhibited an elongated spindle-like shape
(Fig. 8b). However, both MΦGM and MΦM adopted a
rounded shape when seeded on HG, being this morpho-
logical change more evident for MΦGM. MSC encapsu-
lated in HG were more spindle shaped than cells
cultured on TCP (Fig. 8b). We found that the balance
between IL-10 and TNF-α levels secreted from MΦGM
or MΦM on HG suffered important alterations com-
pared with TCP and was characterized by higher IL-10
to TNF-α ratio (Fig. 8c). PGE2 secretion from unprimed
or primed MSC loaded in HG was higher than on TCP
(Fig. 8d). As observed on TCP, priming with CM sub-
stantially increased PGE2 secretion from MSC in HG
(Fig. 8d). This increase was also detected when MΦGM
or MΦM were co-cultured on the HG surface (Fig. 8e, f,
left panels). Incubation of MSC with CM before encap-
sulation in HG enhanced their immunomodulatory
properties on macrophages. Thus, MΦGM or MΦM cul-
tured on MSC-loaded HG secreted lower TNF-α levels
than macrophages cultured on empty HG, an effect fur-
ther enhanced when MSC were primed with CM (Fig. 8e,f, middle panels). Interestingly, IL-10 secretion from
MΦGM increased when HG were loaded with MSC and
further increased when MSC were primed with CM
(Fig. 8e, right panels). High IL-10 levels secreted by
MΦM on HG were unaffected by loading unprimed
MSC whereas increased when MSC were primed with
CM (Fig. 8f, right panels). In all cases, similar effects
were observed by priming MSC with CMGM or CMM.
Taken together, these data indicate that MSC encapsu-
lated in HG enhance the ratio of IL-10 to TNF-α levels
secreted by MΦGM or MΦM and that these immunoreg-
ulatory effects are potentiated by priming MSC with
factors secreted by macrophages.
Discussion
Immunomodulatory effects of MSC are the result of an
integrated response to extracellular stimuli, which
change during the course of wound healing. MSC re-
quire threshold levels of inflammatory factors to activate
their immunosuppressive function whereas insufficient
MSC activation may contribute to potentiate inflamma-
tion [10, 12]. Based on these observations, treatment of
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emerged as an attractive strategy to boost their immuno-
regulatory effects, as shown in animal models of colitis,
acute myocardial ischemia, GvHD, and tendon and liga-
ment healing [22–26]. Classical pro-inflammatory cyto-
kines released at the early stage of inflammation such as
IFN-γ, TNF-α, or IL-1β potentiate paracrine effects of
MSC on macrophages [23, 27–29]. In this work, we show
for the first time that factors originated from
pro-inflammatory or anti-inflammatory macrophages en-
hance immunomodulatory properties of MSC. Our data
show that MSC immunomodulation was enhanced by
priming MSC with CM from LPS-stimulated MΦGM or
MΦM but not by CM from unstimulated macrophages,
supporting the notion that MSC are mainly activated by
inflammatory factors. Priming MSC with CMGM pro-
moted MΦGM polarization toward an anti-inflammatory
phenotype, as evidenced by reduced TNF-α levels and in-
creased IL-10 secretion. Blocking TNF-α in CMGM signifi-
cantly attenuated the immunomodulatory effects of
primed MSC indicating that TNF-α acts as a priming fac-
tor for MSC and therefore plays a critical role in MSC and
macrophage interactions. Interestingly, MSC primed with
CMM reduced TNF-α secretion from MΦGM to a similar
extent than MSC primed with CMGM, suggesting that
MSC can be activated by the cytokine milieu of damagedand repairing tissue. To our knowledge, it remains unclear
whether anti-inflammatory factors influences MSC activa-
tion. Our data show for the first time that IL-10 originated
from anti-inflammatory macrophages contributes to po-
tentiate immunomodulatory functions of MSC. We found
that the ability of primed MSC to reduce TNF-α secretion
from MΦGM was enhanced by the content of TNF-α and
IL-10 in CMM. IL-10 alone was insufficient to potentiate
MSC immunomodulation, but enhanced the priming ef-
fect of TNF-α. These results indicate that MSC activation
by IL-10 is dependent on TNF-α and suggest that IL-10
may act amplifying MSC activation by pro-inflammatory
factors rather than as a priming factor. It is interesting to
note that besides TNF-α and IL-10, CM contain a large
range of soluble factors that may contribute to prime
MSC. The optimal timing for MSC delivery remains un-
certain and likely depends on the inflammatory environ-
ment associated with a specific disease or disorder. MSC
administration at the early inflammatory stage, rather than
after disease stabilization, seems to better guarantee the
achievement of immunosuppressive activity in the case of
acute GvHD [30]. However, the repair phase after acute
myocardial infarction may be a more favorable time for
MSC administration than during the acute injury phase,
in which the hostile microenvironment could impair sur-
vival of transplanted cells [31]. Data herein suggest that
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sponse when transplanted at the onset of resolution, when
both pro-inflammatory and anti-inflammatory factors are
secreted [6], facilitating an effective transition from the
pro-inflammatory phase to tissue repair.MSC-mediated immunomodulation involves a complex
network of cytokines as well as cell to cell interactions.
PGE2 exert anti-inflammatory effects on macrophages via
the cyclic AMP-responsive element (CRE) binding pro-
teins (CREB), which regulate the transcription rates of
Saldaña et al. Stem Cell Research & Therapy           (2019) 10:58 Page 13 of 15several immune-related genes, including TNF-α and
IL-10, upon binding to CRE present in their promoter re-
gions [32]. More recently, it has been described that IL-6
regulates anti-inflammatory macrophage polarization
although underlying mechanism has not been fully eluci-
dated [33, 34]. Using blocking antibodies, we demon-
strated that IL-6 and PGE2 mediate the reduction in
TNF-α secretion from MΦGM in co-cultures with MSC.
Interestingly, CMGM and CMM, which contained high and
low levels of pro-inflammatory factors, respectively, were
similarly effective in stimulating PGE2 secretion by MSC.
This effect may be explained by the IL-10-induced in-
crease in PGE2 levels in the presence of low or high con-
centrations of TNF-α. In this regard, IL-10 has been
shown to enhance MSC activation by other inflammatory
factors, as production of IFN-β and IL-10 by regulatory T
cells synergistically induced expression of the immunoreg-
ulatory factor indoleamine 2,3-dioxygenase (IDO) at the
mRNA level in MSC [35]. However, we did not detect
IDO protein levels in the media of the various cultures
and co-cultures of unprimed or primed MSC (data not
shown). Changes in PGE2 secretion in co-cultures paral-
leled changes in COX2 mRNA levels in MSC indicating
that production of this mediator was regulated at the
mRNA level. The ability of primed MSC to further de-
crease TNF-α secretion by MΦGM could be attributed to
PGE2 but not to IL-6, as indicated in the experiments
using neutralizing antibodies against these mediators.
These data support the notion that MSC immunomodula-
tory potential is strongly related to the production of
PGE2 and suggest that enhancement of the production of
this immunoregulatory factor by anti-inflammatory stim-
uli occurs at the onset of resolution.
It is interesting to note that co-culturing MΦGM with
unprimed MSC or with MSC primed with CMM, which
contained low levels of pro-inflammatory factors, failed to
increase IL-10 secretion. MSC may require strong
activation in a pro-inflammatory milieu to promote
anti-inflammatory signatures in MΦGM as MSC primed
with CMGM led to increased IL-10 levels in co-cultures.
Recent in vitro and in vivo studies show that priming
MSC with TNF-α at 10 ng/ml or higher doses favors
macrophage polarization toward an anti-inflammatory
phenotype [22, 29]. In fact, we detected that blocking
TNF-α in CMGM reduced the ability of primed MSC to
increase IL-10 secretion from MΦGM and that priming
MSC with 10 ng/ml TNF-α alone enhanced IL-10 levels in
co-cultures. Reprograming macrophages to an anti-
inflammatory phenotype has been shown to be mediated
by PGE2 [36]. Supporting this, neutralization of PGE2 in
co-cultures of MΦGM and MSC primed with CMGM re-
duced IL-10 levels. We speculate that PGE2 may promote
IL-10 secretion from MΦGM via the CREB signaling path-
way, as described in cultures of mouse bone marrowmacrophages [37]. Notably, priming MSC with CMM,
which increased PGE2 secretion, did not result in in-
creased IL-10 production in co-cultures with MΦGM, indi-
cating that other factors secreted by MSC cooperate with
PGE2 in macrophage phenotype switching.
Paracrine interactions between MSC and anti-
inflammatory macrophages have been scarcely investi-
gated. MSC, primed or not with CM from macrophages,
regulated TNF-α secretion from MΦM in a similar way
to that observed in co-cultures with MΦGM whereas
IL-10 production showed different trends. As observed
by others [38], IL-10 levels secreted by MΦM decreased
after co-culturing with unprimed MSC. In contrast,
MΦM maintained their anti-inflammatory traits when
co-cultured with MSC primed with inflammatory fac-
tors. These results suggest that the cytokine environ-
ment strongly influences the ability of MSC to control
anti-inflammatory functions of macrophages, allowing
resolution of inflammation or preventing excessive
anti-inflammatory activation that could impair tissue
healing. Moreover, paracrine effects of MSC on MΦM
could be regulated by anti-inflammatory factors secreted
in the resolution of inflammation, as suggested by the
data from experiments in which MSC were primed with
a high concentration of IL-10. It should be mentioned
that changes in IL-10 levels in co-cultures of MΦM were
independent of the PGE2 content, suggesting that differ-
ent signaling pathways regulate IL-10 production in
pro-inflammatory and anti-inflammatory phenotypes.
Murine MSC upregulated the expression of MHC class
II molecules in response to IFN-γ and were rejected after
implantation in immunocompetent MHC-mismatched
mice [39–41]. In human MSC, the expression of both
HLA classes I and II increased after treatment with IFN-γ
[20]. Our data show that treatment of MSC with CM
increased surface expression of HLA class I but not of
HLA class II, which could be attributed to an inhibitory
effect of factors contained in the CM. For example, trans-
forming growth factor-β (TGF-β) has been shown to re-
duce IFN-γ-induced expression of HLA class II in human
MSC [42]. One approach to improve stem cell-based ther-
apies is the use of biomaterial carriers. Type I collagen
HG have been successfully used as drug delivery vehicles
for the treatment of long bone fracture and spinal fusion
[43]. Moreover, collagen HG have been explored to in-
crease MSC survival after implantation and prevent im-
mune rejection in vivo [44]. We observed that collagen
HG are instructive microenvironments for macrophages
and MSC functions as well as for the crosstalk between
both cell types. Collagen HG substantially decreased
pro-inflammatory activation of MΦGM and potentiated
anti-inflammatory activity of MΦM as compared to 2D
substrates. Increased PGE2 secretion and greater immuno-
modulatory activity were observed in MSC cultured in
Saldaña et al. Stem Cell Research & Therapy           (2019) 10:58 Page 14 of 15three-dimensional (3D) topographies [45] or in spheroids
[46], effects that were attributed to 3D disposition of
MSC. Our data suggest that encapsulation of MSC in
HG is an effective approach to enhance immunomodula-
tory properties of MSC. MSC in HG promoted anti-
inflammatory switching of MΦGM, as indicated by marked
reduction in TNF-α levels and increase in IL-10 produc-
tion, and sustained MΦM activation characterized by high
IL-10 secretion. Priming with CM conferred to MSC
loaded in HG greater immunomodulatory potential, pro-
moting MΦGM polarization toward an anti-inflammatory
phenotype and supporting MΦM anti-inflammatory acti-
vation. Enhanced immunoregulatory effects of primed
MSC in HG were probably a result of the substantial in-
crease in PGE2 levels compared to unprimed counterparts.
Taken together, our results show that priming MSC with
inflammatory factors originated from macrophages en-
hances their immunomodulatory potential. In fact, recent
preclinical data supports the safety of IFN-γ-primed MSC
infused in mice and their effectiveness to treat
immune-related diseases [23, 47]. Encapsulation of primed
MSC in HG could be an effective approach to improve
their therapeutic efficacy upon implantation. Further stud-
ies are required to elucidate the in vivo immunomodula-
tory potential of primed MSC loaded in HG.
Conclusions
Factors secreted by pro-inflammatory and anti-inflammatory
macrophages activate the immunomodulatory potential of
MSC. This was attributed, at least in part, to the priming
effect of TNF-α and was associated with an increase in
PGE2 production by MSC. We identified that IL-10 secreted
from anti-inflammatory macrophages, in combination with
other inflammatory factors, activate MSC to secrete PGE2
and potentiate the priming effect of TNF-α. Encapsulation
of primed MSC in collagen HG enhances their immuno-
regulatory function, promoting anti-inflammatory activity of
macrophages. These findings contribute to the understand-
ing of the mechanisms by which macrophages polarization
dynamics instruct MSC and may provide a basis for the de-
velopment of novel strategies to enhance MSC immunoreg-
ulatory potential.
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